More than 24 hours of content in english.
Program :
Welcome to Roma: Caput Mundi - M. Antonelli (Rome, Italy)
Welcome to the meeting Renal failure in the ICU - J-L. Vincent (Brussels, Belgium)
Evolution of our technologies - C. Ronco (Vicenza, Italy)
Plans for the meeting - faculty
Basic Concepts :
Mechanisms of solute transport across membranes - C. Ronco (Vicenza, Italy)
Principles of extracorporal circulation - Z. Ricci (Rome, Italy)
Vascular access - R. Bellomo (Melbourne, Australia)
The classical prescription of dialysis - P. Saudan (Geneva, Switzerland)
Monitoring and Control of Delivery
Pre or post dilution - Monitoring of the extracorporeal circuit - Z. Ricci (Rome, Italy)
Control of treatment delivery - D. Payen (Paris, France)
Optimal ultrafiltration - J. Prowle (London, UK)
Electrolytes management - O. Joannes-Boyau (Bordeaux, France)
How can biomakers help ?
J. Kellum (Pittsburgh, USA)
When to start ? When to stop ?
When should we start RTT ? - J. Kellum (Pittsburgh, USA)
When should we stop RTT ? - P. Pickkers (Nijmegen, the Netherlands)
Round Table Discussiopn - R Bellomo (Melbourne, Australia), J. Kellum (Pittsburgh, USA), C. Ronco (Vicenza, Italy), M. Joannidls (Innsbruck, Austria), P. Pickkers (Nikmegen, The Netherlands)
Modality Intermittent vs continuous RRT
Intermittent RTT is OK - J. Prowle (London, UK)
I prefer continuous RRT - R. Bellomo (Melbourne, Australia)
SLED may be the best option - M. Joannidis (Innsbruck, Austria)
RRT in special situations
RRT in neurologic crises - F. Taccone (Brussels, Belgium)
RRT in cardiac failure - J. Prowle (London, UK)
RRT in respiratory failure - M. Joannidis (Innsbruck, Austria)
The shortcomings
Frequent problems - Z. Ricci (Rome, Italy)
Temperature control: is it important ? - M. Joannidis (Innsbruck, Austria)
Electrolyde disorders (Hypophophaternia, hypomagnesemia...) - D. Payen (Paris, France)
Antibiotic therapy during RRT - M. Antonelli (Rome, Italy)F. Taciibe (Brussels, Belgium)
Elimination of other drugs - O. Joannes - Boyau (Bordeaux, France)
Anticoagulation
Heparins, heparinoids and direct thrombin inhibitors - M. Joannidis (Innsbruck, Austria)
Citrate anticoagulation - P. Skeuden (Geneva, Switzerland)
The problems with citrate - O. Joannes-Boyau (Bordeaux, France)
When to use one vs the other - D. De Backer (Brussels, Belgium)
Removal of bad humors
Is there a rationale for RRT in sepsis ? - D. De Baker (Brussels, Belgium)
Coupled plasma filtration - E. Turani (Rome, Italy)
Polymoxin - B. hemoperfusion - M. Antonelli (Rome, Italy)
MOST - C. Ronco (Vicenza, Italy)
How to enhance treatment performance ?
High volume is better - C. Ronco (Vicenza, Italy)
High permeability is better - R. Bellomo (Melbourne, Australia)
High adsorption is better - J. Kellum (Pittsburgh, USA)
Round table discussions
Vascular access - O. Joannes-Boyau (Bordeaux, France), D. Payen (Paris, France), E. Turani (Rome, Italy)F. Taccono (Brussels, Belgium)
Clooting and bleeding - M. Joannidia (Innsbruck, Austria), D. De Bakcer (Brussels, Belgium), R. Bellomo (Melbourne, Australia), P. Saudan (Geneva, Switzerland), O. Joannes-Boyau (Bordeaux, France)
Technical complications and troubleshooting - R. Bellomo (Melbourne, Australia), C. Ronco (Vicenz, Italy), Z. Ricci (Roma, Italy), P. Pickkers (Njimegen, the Netherlands)
How to guide fluid withdrawal - just by formula ? - M. Antonelli (Rome, Italy), D. De Becker (Brussels, Belgium), D. Payen (Paris, France), J. Prowle (London, UK)
My small tricks
All the faculty
Conclusions
The take messages - Plans for publication